Clinical outcomes of valve-sparing reconstructive surgery for ischemic mitral regurgitation: a 5-year single-center report and review of current global trends
DOI:
https://doi.org/10.14739/2310-1210.2025.4.331047Keywords:
coronary heart disease, mitral regurgitation, artificial circulation, coronary artery bypass grafting, mitral valve reconstructionAbstract
The presence of ischemic mitral regurgitation (MR) is associated with increased morbidity and mortality. Following acute myocardial infarction, the incidence of ischemic MR ranges from 17 % to 55 %. The optimal choice of surgical treatment for moderate and severe mitral valve (MV) insufficiency of ischemic origin remains a controversial issue for cardiologists and cardiac surgeons, despite the recommendations of current guidelines.
Aim. To enhance treatment outcomes for patients with ischemic MR by identifying the frequency and determinants of adverse postoperative events following sustained restoration of MV function over the long term.
Materials and methods. A single-center retrospective observational study was conducted, analyzing clinical data from 32 consecutive patients with MV insufficiency operated on at the Zaporizhzhia Regional Clinical Hospital from 01.01.2020 to 31.12.2024. The average postoperative observation period was 14.5 ± 5.9 months (minimum – 6, maximum – 24 months). The average age of the patients was 62.3 ± 7.1 years. By gender, the studied patients were distributed as follows: women – 7 (21.88 %), men – 25 (78.12 %).
Results. The mean ICU stay was 4.0 ± 2.2 days. The total length of hospital stay was 15.7 ± 4.8 days. The in-hospital mortality rate was 9.38 %. The most common cause of early mortality in the postoperative period was acute cardiovascular failure. At the time of discharge, 4 (13.8 %) patients had no residual MR. Minimal (trivial) MR was detected in 15 (51.72 %) patients, mild MR in 7 (24.14 %) patients, and moderate MR in 3 (10.35 %) patients. In the early postoperative period, there were no reoperations due to the progression of residual MR. In the long-term period, no fatalities were noted during the follow-up. Freedom from moderate and severe MR amounted to 80 % in the long-term postoperative period.
Conclusions. Early surgical intervention is recommended to improve the long-term treatment results of ischemic MR. Durable restoration of mitral valve function can be achieved with low perioperative mortality and favorable long-term survival. In late stages of severe MR, replacement of the MV is recommended instead of surgical repair.
References
Johannesen SL, Barker CM, Levack MM. Adjunctive Techniques for Repair of Ischaemic Mitral Regurgitation. Card Fail Rev. 2021;7:e20. doi: https://doi.org/10.15420/cfr.2021.06
Mil-Homens Luz F, Amorim MJ. Ischaemic mitral regurgitation - to repair or replace? Looking beyond the valve. Port J Card Thorac Vasc Surg. 2022;29(1):25-34. doi: https://doi.org/10.48729/pjctvs.253
Senthilnathan GV, Subramaniyan B, Murugan S, Veeramani V. Clinical presentation and prognosis of non valvular mitral regurgitation – a single institution experience. Clin Epidemiol Glob Health. 2021;12:100781. doi: https://doi.org/10.1016/j.cegh.2021.100781
Grayburn PA, Thomas JD. Basic principles of the echocardiographic evaluation of mitral regurgitation. JACC Cardiovasc Imaging. 2021;14(4):843-53. doi: https://doi.org/10.1016/j.jcmg.2020.06.049
Nelson JA, Espinosa R, Michelena H, Rehfeldt K. Acute severe functional mitral regurgitation after non-mitral valve cardiac surgery – left ventricular dyssynchrony as a potential mechanism. J Cardiothorac Vasc Anesth. 2021;35(5):1292-8. doi: https://doi.org/10.1053/j.jvca.2020.08.045
Nappi F, Antoniou GA, Nenna A, Michler R, Benedetto U, Avtaar Singh SS, et al. Treatment options for ischemic mitral regurgitation: a meta-analysis. J Thorac Cardiovasc Surg. 2022;163(2):607-622.e14. doi: https://doi.org/10.1016/j.jtcvs.2020.05.041
Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular heart disease epidemiology. Med Sci (Basel). 2022;10(2):32. doi: https://doi.org/10.3390/medsci10020032
Roth GA, Mensah GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risks: A Compass for Global Action. J Am Coll Cardiol. 2020;76(25):2980-1. doi: https://doi.org/10.1016/j.jacc.2020.11.021
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022 Feb 12;43(7):561-632. doi: https://doi.org/10.1093/eurheartj/ehab395. Erratum in: Eur Heart J. 2022;43(21):2022. doi: https://doi.org/10.1093/eurheartj/ehac051
Doig F, Lu ZQ, Smith S, Naidoo R. Long term survival after surgery for ischaemic mitral regurgitation: a single centre Australian experience. Heart Lung Circ. 2021;30(4):612-9. doi: https://doi.org/10.1016/j.hlc.2020.08.015
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e35-e71. doi: https://doi.org/10.1161/CIR.0000000000000932. Erratum in: Circulation. 2021;143(5):e228. doi: https://doi.org/10.1161/CIR.0000000000000960. Erratum in: Circulation. 2021;143(10):e784. doi: https://doi.org/10.1161/CIR.0000000000000966
Bonow RO, O'Gara PT, Adams DH, Badhwar V, Bavaria JE, Elmariah S, et al. 2020 Focused update of the 2017 ACC expert consensus decision pathway on the management of mitral regurgitation: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020;75(17):2236-70. doi: https://doi.org/10.1016/j.jacc.2020.02.005. Erratum in: J Am Coll Cardiol. 2020;75(23):3000. doi: https://doi.org/10.1016/j.jacc.2020.04.051
Dietze Z, Marin-Cuartas M, Berkei L, De La Cuesta M, Otto W, Pfannmüller B, et al. Mitral valve replacement versus repair for severe mitral regurgitation in patients with reduced left ventricular ejection fraction. JTCVS Open. 2024;22:191-207. doi: https://doi.org/10.1016/j.xjon.2024.07.021
Andrási TB, Glück AC, Ben Taieb O, Talipov I, Abudureheman N, Volevski L, et al. Outcome of surgery for ischemic mitral regurgitation depends on the type and timing of the coronary revascularization. J Clin Med. 2023;12(9):3182. doi: https://doi.org/10.3390/jcm12093182
Senzai M, Kainuma S, Toda K, Miyagawa S, Yoshioka D, Kawamura T, et al. Clinical outcomes after durable mitral valve repair for ischemic mitral regurgitation. Ann Thorac Surg. 2022;114(1):115-24. doi: https://doi.org/10.1016/j.athoracsur.2021.08.016
Moroz VS, Lazoryshynets VV. [Analysis of echocardiography indicators depending on the type of surgical correction of the mitral valve in patients with ischemic heart disease]. Ukr J Cardiovasc Surg. 2024;32(3):45-50. Ukrainian. doi: https://doi.org/10.30702/ujcvs/24.32(03)/ML044-4550
Kusunose K, Obuchowski NA, Gillinov M, Popovic ZB, Flamm SD, Griffin BP, et al. Predictors of mortality in patients with severe ischemic cardiomyopathy undergoing surgical mitral valve intervention. J Am Heart Assoc. 2017;6(11):e007163. doi: https://doi.org/10.1161/JAHA.117.007163
Kwon DH, Huang S, Turkmani M, Salam D, Al-Dieri D, Wang TM, et al. Cardiac MRI-enriched phenomapping classification and differential treatment outcomes in patients with ischemic cardiomyopathy. Circ Cardiovasc Imaging. 2024;17(4):e016006. doi: https://doi.org/10.1161/CIRCIMAGING.123.016006
Kron IL, Hung J, Overbey JR, Bouchard D, Gelijns AC, Moskowitz AJ, et al. J Thorac Cardiovasc Surg. 2015;149(3):752-61.e1. doi: https://doi.org/10.1016/j.jtcvs.2014.10.120
Nonaka DF, Fox AA. Ischemic mitral regurgitation: repair, replacement or nothing. Semin Cardiothorac Vasc Anesth. 2019;23(1):11-9. doi: https://doi.org/10.1177/1089253218792921
Harmel EK, Reichenspurner H, Girdauskas E. Subannular reconstruction in secondary mitral regurgitation: a meta-analysis. Heart. 2018;104(21):1783-90. doi: https://doi.org/10.1136/heartjnl-2017-312277
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 V. V. Osaulenko, V. O. Hubka, K. O. Chmul, S. Yu. Nakonechnyi, R. I. Budahov
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. 
